118 related articles for article (PubMed ID: 36199185)
21. The role of Beclin 1 in IR-induced crosstalk between autophagy and G2/M cell cycle arrest.
Liang N; Liu X; Zhang S; Sun H
Cell Signal; 2019 Oct; 62():109353. PubMed ID: 31260798
[TBL] [Abstract][Full Text] [Related]
22. Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.
Wang Y; Singh R; Wang L; Nilsson M; Goonatilake R; Tong P; Li L; Giri U; Villalobos P; Mino B; Rodriguez-Canales J; Wistuba I; Wang J; Heymach JV; Johnson FM
Oncotarget; 2016 Jul; 7(30):47998-48010. PubMed ID: 27384992
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest.
Zhou J; Chang M; Li J; Fang T; Hu J; Bai C
Respir Res; 2018 May; 19(1):96. PubMed ID: 29784046
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
26. Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
Park YK; Kim KM; Lee YJ; Kim KH; Lee SG; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Korean Med Sci; 2011 Feb; 26(2):214-21. PubMed ID: 21286012
[TBL] [Abstract][Full Text] [Related]
27. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
Hong YS; Hong SW; Kim SM; Jin DH; Shin JS; Yoon DH; Kim KP; Lee JL; Heo DS; Lee JS; Kim TW
Int J Oncol; 2012 Jul; 41(1):76-82. PubMed ID: 22552540
[TBL] [Abstract][Full Text] [Related]
28. DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21.
Tian Y; Wang L; Chen X; Zhao Y; Yang A; Huang H; Ouyang L; Pang D; Xie J; Liu D; Tu P; Li J; Hu Z
Biochem Pharmacol; 2023 May; 211():115518. PubMed ID: 36966937
[TBL] [Abstract][Full Text] [Related]
29. RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point.
Ergul M; Bakar-Ates F
Anticancer Agents Med Chem; 2019; 19(15):1846-1854. PubMed ID: 31244432
[TBL] [Abstract][Full Text] [Related]
30. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1).
Luo P; Yan H; Du J; Chen X; Shao J; Zhang Y; Xu Z; Jin Y; Lin N; Yang B; He Q
Autophagy; 2021 Oct; 17(10):3221-3237. PubMed ID: 33315519
[TBL] [Abstract][Full Text] [Related]
31. Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.
Deng LJ; Peng QL; Wang LH; Xu J; Liu JS; Li YJ; Zhuo ZJ; Bai LL; Hu LP; Chen WM; Ye WC; Zhang DM
Oncotarget; 2015 Oct; 6(33):34258-75. PubMed ID: 26485758
[TBL] [Abstract][Full Text] [Related]
32. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
[No Abstract] [Full Text] [Related]
33. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.
Chaudhary P; Sharma R; Sahu M; Vishwanatha JK; Awasthi S; Awasthi YC
J Biol Chem; 2013 Jul; 288(28):20532-46. PubMed ID: 23733185
[TBL] [Abstract][Full Text] [Related]
34. Ovatodiolide isolated from Anisomeles indica induces cell cycle G2/M arrest and apoptosis via a ROS-dependent ATM/ATR signaling pathways.
Yu CY; Jerry Teng CL; Hung PS; Cheng CC; Hsu SL; Hwang GY; Tzeng YM
Eur J Pharmacol; 2018 Jan; 819():16-29. PubMed ID: 28986085
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
36. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
[TBL] [Abstract][Full Text] [Related]
37. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Wu G; Lin N; Xu L; Liu B; Feitelson MA
BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
[TBL] [Abstract][Full Text] [Related]
38. Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.
Giannelli G; Azzariti A; Fransvea E; Porcelli L; Antonaci S; Paradiso A
Br J Cancer; 2004 Nov; 91(11):1964-9. PubMed ID: 15545972
[TBL] [Abstract][Full Text] [Related]
39. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
Wang Y; Wu L; Yao Y; Lu G; Xu L; Zhou J
Cancer Lett; 2018 Nov; 436():1-9. PubMed ID: 30118839
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.
Zhao D; Yang Z; Chen C; Zhang Z; Yu Y; Li Z
FEBS Open Bio; 2021 Nov; 11(11):3115-3125. PubMed ID: 34555268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
